唐波

团队介绍

唐波，男, 1985.2，药剂学博士,伟德BEVICTOR(中国)有限公司，讲师

研究方向：

眼部新型给药系统，缓控释制剂

基金项目：

江苏省自然科学基金（青年项目），BK20170445，靶向新型有机阳离子转运体的眼用前药递送系统的研究， 2017-07 至 2020/06，20万，已结题，主持

江苏省高校自然科学研究面上项目，17KJB350009，基于核壳共载的白蛋白纳米制剂克服肿瘤多药耐药的研究，2017-07 至 2019-06，3万元，已结题，主持

国家自然科学基金面上项目，81073064，载体控制型中药多组分同步缓释技术的研究，2011-01 至 2011-12，10万元，已结题，参加

代表性论文：

(1) Fang Guihua and Tang Bo*, Current advances in nano-delivery of celastrol for treating inflammation associated diseases, Journal of Materials Chemistry B, 2020, 8(48)，10954-10965.

(2)Fang Guihua, Tang Bo*, Advanced delivery strategies facilitating oral absorption of heparins, Asian Journal of Pharmaceutical Sciences, 2020, 15(4), 449-460.

(3) Tang Bo, Qian Yu, Fang Guihua *. Development of Lipid–Polymer Hybrid Nanoparticles for Improving Oral Absorption of Enoxaparin. Pharmaceutics , 2020, 12(7), 607-618.

(4) Tang Bo, Liu Zhihong, Tian Zhen, Zhang Jing, Chen Xu, Fang Guihua, Song Hongtao*，Development and evaluation of synchronized and sustained release Tripergium Wilfordii tablets based hot-melt extrusion and direct powder compression, Journal of Drug Delivery Science and Technology, 2019, 53，101208-101217

(9) Tang Bo, Fang Guihua, Gao Ying, Liu Yi, Liu Jinwen, Zou Meijuan, Wang Lihong, Cheng Gang *, Lipid-albumin nanoassemblies co-loaded with borneol and paclitaxel for intracellular drug delivery to C6 glioma cells with P-gp inhibition and its tumor targeting, Asian Journal of Pharmaceutical Sciences, 2015, 10, 363-371.